A Richer Texture, a New Ingredient, or Different Packaging Can All Affect the Product File
When updating a winter skincare product, begin by listing what has actually changed. Then check each change against the Product Information File (PIF). If the formula, ingredients, packaging, directions, or claims have changed, the existing records need to be reviewed to see whether they still apply.
A lightweight cream may become richer for winter. A serum may gain a featured ingredient. A mask may switch to a thicker sheet, while its product page introduces a “focused winter care” message.
These can all be sensible seasonal updates. But if the team continues to use the previous formula’s test reports, ingredient records, and safety assessment, the PIF may no longer describe the product about to be launched.
Taiwan introduced PIF requirements in stages. Under the TFDA’s published schedule, other cosmetics within the scope of the rules, apart from the stated exceptions, became subject to PIF requirements on July 1, 2026. A winter update is therefore a good reason to include a PIF review early in the development schedule.
-
Start With a Previous-Version Versus New-Version Comparison
Before reviewing the PIF, define the scope of the update.
| What changed | Records to check first |
| Oils, moisturizers, or other formula proportions | Complete formula, ingredient records, stability data, and safety assessment |
| Featured ingredients such as PDRN or exosomes | Ingredient identity, source, specifications, conditions of use, and supporting documents |
| Bottle, tube, or mask sachet | Packaging specifications, compatibility, and finished-product stability |
| Pack size or directions for use | Labeling, expected amount used, and conditions assumed in the safety assessment |
| Specific claims such as “long-lasting hydration” | Supporting finished-product evidence and promotional copy |
| Visual design only | Whether the new label, name, imagery, and copy still agree with the product file |
This comparison gives planning, development, regulatory, and design teams a shared view of which existing records need another look and which new records are still missing. Whether additional testing or reassessment is needed depends on the nature of the change and whether the existing evidence covers the updated product.
-
If the Formula Is Richer, Does the Existing Stability Data Still Apply?
Winter creams often gain a softer, richer texture through changes to their oils, thickening system, or moisturizing ingredients. Even if the name changes only slightly, the formula itself may be different.
Check whether:
- The complete formula in the PIF reflects the new version.
- Ingredient specifications and supplier records match the materials selected.
- Existing stability data support the updated formula and intended shelf life.
- The cream’s appearance, odor, texture, and any signs of separation meet its quality specifications.
- The formula changes call for another review by the safety assessor.
The TFDA’s PIF preparation guidance discusses product stability data and indicates that the formula and packaging material used in testing should correspond to the product being assessed. The question is whether an older report can still support the updated finished product.
-
When Adding a Featured Ingredient, Update More Than the Front Label
If a winter update adds PDRN, exosomes, peptides, or ceramides, the design team can quickly place the new ingredient name on the packaging. The PIF review needs to go further.
Check the ingredient’s labeling name, composition, supplier specifications, safety information, actual addition rate, and conditions of use in the new formula. If supplier materials highlight a concentration or particle count, establish whether the number refers to the supplied ingredient, the amount added, or the finished product.
For exosomes derived from human cells, the team must also check the specific ingredient’s review status and current documentation requirements in Taiwan. The TFDA revised the annex to the relevant case-by-case review requirements on February 2, 2026.
From a planning perspective, adding an ingredient is complete when its documents, the actual formula, and the public description all agree.
-
A New Bottle or Sachet Calls for a Packaging Review
Winter updates often include packaging changes: a dropper serum becomes a pump product, a cream moves into a wide-mouth jar, or a mask gets a different sachet or sheet material.
Even when the formula stays the same, check whether the new package affects storage or dispensing. Can the pump deliver a thicker cream reliably? Is the new container suitable for the contents? Does a different sachet still meet the product’s quality needs?
The TFDA guidance discusses packaging specifications and material information, along with data that may address packaging stability or compatibility with the formula. Packaging changes therefore call for coordination with development and quality teams.
-
If the Directions Change, Revisit the Conditions Used in the Safety Assessment
A formula’s intended use changes if a product previously presented as an occasional care step becomes an “every morning and evening” product, or if directions expand from a small area to the entire face.
Compare the new instructions with the conditions used in the existing safety assessment, including the application area, frequency, amount per use, and whether the product is rinsed off. A change in pack size is also worth checking, particularly if it comes with a different dispensing method or period of use after opening.
The aim is to make sure the use described in the PIF matches the directions consumers will actually read.
-
Which New “Winter Intensive Care” Claims Need Evidence?
An update can change what consumers expect from the product, even when the formula changes very little.
“A soft, nourishing feel” and “suited to the dry season” are different kinds of statements from “48-hour hydration” or “improves the appearance of dryness by X% after two weeks.” Specific, measurable claims need evidence that applies to the finished product. An ingredient presentation or results from a previous formula may not support them.
Review the product name, packaging, website copy, imagery, and social content together. Their overall message should match the updated product and the evidence available. Taiwan’s rules on cosmetic labeling and advertising consider the meaning conveyed by these elements as a whole.
-
Before Artwork Approval, Check Four Sets of Records Against the Same Version
Place these items side by side before approving the updated packaging:
- Approved formula and ingredient records: Check ingredient names, sources, and specifications.
- Updated product and test records: Check which version the stability, quality, and safety information covers.
- Actual packaging and directions: Check the container, pack size, and method of use.
- Final packaging and product-page copy: Check the product name, ingredient list, and basis for each claim.
When these records refer to different versions, the team can end up with updated packaging and a PIF that still describes the old formula. The TFDA provides PIF preparation guidance and a checklist to help teams review the file item by item.
Conclusion: Every Change Needs a Corresponding Record
A winter skincare update may bring a richer texture, easier dispensing, or a new ingredient concept. Each change can also affect whether the existing PIF still describes the product accurately.
Start with a comparison of the previous and new versions, then review the formula, ingredients, finished-product tests, packaging, intended use, and claims. The update is ready when the file, the product itself, and the public-facing copy all describe the same version.